Background Although surgical resection is considered the standard of care for early-stage
non-small cell lung cancer, radiotherapy [stereotactic body radiation therapy (SBRT)] has …

Objective To examine disease control and survival after stereotactic body radiotherapy
(SBRT) for medically inoperable, early-stage non–small cell lung cancer (NSCLC) and …

Introduction The purpose of the present study was to evaluate the role of renin-angiotensin
system (RAS) inhibitors in preventing symptomatic radiation pneumonitis (RP) after …

Lung stereotactic ablative radiotherapy (SABR) is a method of delivering high
'ablative'doses of radiotherapy to tumours in the lung. It was developed at the Karolinska …

Background This study was designed to define clinical baseline parameters associated with
impaired survival of patients with stage I or II non-small cell lung cancer (NSCLC) who …

Purpose Although adjuvant systemic therapy (ST) is often recommended for the treatment of
patients with high-risk, early-stage non-small cell lung carcinoma (NSCLC) after surgery …

Personal health records (PHRs) have lots of benefits for things such as health surveillance,
epidemiological surveillance, self-control, links to various services, public health and health …

Objective Several options are available for the local treatment of colorectal pulmonary
metastases; however, the efficacy of each treatment has not been well characterized. We …

Objectives We investigated the patient's perspective on SBRT for treatment of stage I
NSCLC and compared the patient's perspective of SBRT to that of surgery. Materials and …

Objective No randomized controlled trials comparing stereotactic body radiotherapy and
lobectomy for operable early-stage non–small-cell lung cancer have been successfully …